Compile Data Set for Download or QSAR
Report error Found 173 Enz. Inhib. hit(s) with all data for entry = 1841
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343230(1-methyl-4-(5-methylpyridin-2-yl)-N-(2-phenylimida...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343231(1-methyl-4-(4-methylthiazol-2-yl)-N-(2-phenylimida...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343234(1-methyl-N-(2-phenylimidazo[1,2-a]pyridin-7-yl)-4-...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343235(1-methyl-N-(2-phenylimidazo[1,2-a]pyridin-7-yl)-4-...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343232(4-(4-(difluoromethyl)thiazol-2-yl)-1-methyl-N-(2-p...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343233(4-(4-(difluoromethyl)-5-methylthiazol-2-yl)-1-meth...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343237(1-methyl-4-(5-methyl-1,3,4-thiadiazol-2-yl)-N-(2-p...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343247(4-(6-methoxypyridin-2-yl)-1-methyl-N-(2-phenyl-5,6...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343244(N-(2-(3-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343245(1-methyl-4-(6-methylpyridin-2-yl)-N-(2-phenyl-5,6,...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343250(4-(3-isopropyl-1,2,4-thiadiazol-5-yl)-1-methyl-N-(...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343251(1-methyl-4-(5-methylthiazol-2-yl)-N-(2-phenyl-5,6,...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343248(1-methyl-4-(2-methylthiazol-4-yl)-N-(2-phenyl-5,6,...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343249(1-methyl-4-(6-methylpyrazin-2-yl)-N-(2-phenyl-5,6,...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343238(4-(4-(difluoromethyl)thiazol-2-yl)-N-(2-(3-fluorop...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343239(1-methyl-N-(2-phenyl-5,6,7,8-tetrahydroimidazo[1,2...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343236(4-(5-chloro-4-(difluoromethyl)thiazol-2-yl)-1-meth...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343237(1-methyl-4-(5-methyl-1,3,4-thiadiazol-2-yl)-N-(2-p...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343242(4-(4-(difluoromethyl)-5-methylthiazol-2-yl)-1-meth...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343243(4-(4-(difluoromethyl)-5-methylthiazol-2-yl)-N-(2-(...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343240(4-(4-(difluoromethyl)thiazol-2-yl)-1-methyl-N-(2-p...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343241(4-(5-chloro-4-(difluoromethyl)thiazol-2-yl)-1-meth...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343266(N-(6-fluoro-2-phenyl-[1,2,4]triazolo[1,5-a]pyridin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343267(US9777000, Example 3.20 | 4-(5-chloro-4-(difluorom...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343264(4-(4-(difluoromethyl)thiazol-2-yl)-N-(2-(4-fluorop...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343265(N-(2-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343255(N-(3-fluoro-2-phenyl-5,6,7,8-tetrahydroimidazo[1,2...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343258(1-methyl-4-(4-methylpyridin-2-yl)-N-(2-phenyl-5,6,...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343238(4-(4-(difluoromethyl)thiazol-2-yl)-N-(2-(3-fluorop...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343278(4-(3-cyanopyridin-2-yl)-N-(6-fluoro-2-phenyl-[1,2,...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343279(4-(3,6-dimethyl-pyrazin-2-yl)-N-(6-fluoro-2-phenyl...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343276(4-(4,6-dimethylpyridin-2-yl)-N-(6-fluoro-2-phenyl-...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343277(4-(4-(difluoromethyl)thiazol-2-yl)-N-(6-fluoro-2-p...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343282(4-(4-(difluoromethyl)thiazol-2-yl)-N-(2-(3-fluorop...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343283(4-(4-ethylthiazol-2-yl)-1-methyl-N-(2-phenyl-[1,2,...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343280(4-(4-(difluoromethyl)thiazol-2-yl)-1-methyl-N-(2-p...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343281(4-(4-(difluoromethyl)thiazol-2-yl)-N-(2-(2-methoxy...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343270(US9777000, Example 3.50 | 4-(2,5-dimethylpyrimidin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343271(N-(6-fluoro-2-phenyl-[1,2,4]triazolo[1,5-a]pyridin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343268(US9777000, Example 3.30 | 4-(2,6-dimethylpyrimidin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343269(US9777000, Example 3.40 | 4-(2,6-dimethoxypyrimidi...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343274(N-(6-fluoro-2-phenyl-[1,2,4]triazolo[1,5-a]pyridin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343266(N-(6-fluoro-2-phenyl-[1,2,4]triazolo[1,5-a]pyridin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343272(N-(6-fluoro-2-phenyl-[1,2,4]triazolo[1,5-a]pyridin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343273(N-(6-fluoro-2-phenyl-[1,2,4]triazolo[1,5-a]pyridin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343294(4-(5-chloropyrimidin-4-yl)-N-(6-fluoro-2-phenyl-[1...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343268(US9777000, Example 3.30 | 4-(2,6-dimethylpyrimidin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343292(4-(5-fluoro-2-methoxypyrimidin-4-yl)-N-(6-fluoro-2...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343293(N-(6-fluoro-2-phenyl-[1,2,4]triazolo[1,5-a]pyridin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
Mochida Pharmaceutical

US Patent
LigandPNGBDBM343298(N-(6-fluoro-2-phenyl-[1,2,4]triazolo[1,5-a]pyridin...)
Affinity DataIC50: 5nMAssay Description:IMAP TR-FRET Phosphodiersterase Evaluation Assay Kit (Molecular Device) was used for the measurement. Ten μL of a diluted test compound having e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2019
Entry Details
US Patent

Displayed 1 to 50 (of 173 total ) | Next | Last >>
Jump to: